世界のイマチニブ薬市場2021-2026:カプセル、錠剤

LP Informationが発行した調査報告書(LPI21MY9644)
◆英語タイトル:Global Imatinib Drugs Market Growth 2021-2026
◆商品コード:LPI21MY9644
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年5月(※2024年版があります。お問い合わせください)
◆ページ数:139
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LPインフォメーション社の「イマチニブ薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、カプセル、錠剤など、用途別には、病院、ドラッグストア、その他などにセグメント区分してまとめました。イマチニブ薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・イマチニブ薬の世界市場概要(サマリー)
・イマチニブ薬の企業別販売量・売上
・イマチニブ薬の企業別市場シェア
・イマチニブ薬の世界市場規模 2016年-2021年:種類別(カプセル、錠剤)
・イマチニブ薬の世界市場規模 2016年-2021年:用途別(病院、ドラッグストア、その他)
・イマチニブ薬の南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・イマチニブ薬のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・イマチニブ薬のヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・イマチニブ薬の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・イマチニブ薬市場の成長要因・課題・動向
・イマチニブ薬の世界市場予測 2021年-2026年
・イマチニブ薬の南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・イマチニブ薬のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・イマチニブ薬のヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・イマチニブ薬の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・イマチニブ薬の世界市場予測:種類別(カプセル、錠剤)
・イマチニブ薬の世界市場予測:用途別(病院、ドラッグストア、その他)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Imatinib Drugs will have significant change from previous year. By the most conservative estimates of global Imatinib Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Imatinib Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Imatinib Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Capsules
Tablets

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospitals
Drug Stores
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Apotex Inc.
Novartis
Sanofi S.A.
Cipla Inc.
Mylan Pharms Inc.
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy’s Laboratories
Teva Pharmaceutical Industries Ltd.

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Imatinib Drugs Consumption 2016-2026
2.1.2 Imatinib Drugs Consumption CAGR by Region
2.2 Imatinib Drugs Segment by Type
2.2.1 Capsules
2.2.2 Tablets
2.3 Imatinib Drugs Sales by Type
2.3.1 Global Imatinib Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Imatinib Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Imatinib Drugs Sale Price by Type (2016-2021)
2.4 Imatinib Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Drug Stores
2.4.3 Other
2.5 Imatinib Drugs Sales by Application
2.5.1 Global Imatinib Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Imatinib Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Imatinib Drugs Sale Price by Application (2016-2021)

3 Global Imatinib Drugs by Company
3.1 Global Imatinib Drugs Sales Market Share by Company
3.1.1 Global Imatinib Drugs Sales by Company (2019-2021)
3.1.2 Global Imatinib Drugs Sales Market Share by Company (2019-2021)
3.2 Global Imatinib Drugs Revenue Market Share by Company
3.2.1 Global Imatinib Drugs Revenue by Company (2019-2021)
3.2.2 Global Imatinib Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Imatinib Drugs Sale Price by Company
3.4 Global Manufacturers Imatinib Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Imatinib Drugs Product Location Distribution
3.4.2 Players Imatinib Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Imatinib Drugs by Region
4.1 Global Imatinib Drugs by Region
4.1.1 Global Imatinib Drugs Sales by Region
4.1.2 Global Imatinib Drugs Revenue by Region
4.2 Americas Imatinib Drugs Sales Growth
4.3 APAC Imatinib Drugs Sales Growth
4.4 Europe Imatinib Drugs Sales Growth
4.5 Middle East & Africa Imatinib Drugs Sales Growth

5 Americas
5.1 Americas Imatinib Drugs Sales by Country
5.1.1 Americas Imatinib Drugs Sales by Country (2016-2021)
5.1.2 Americas Imatinib Drugs Revenue by Country (2016-2021)
5.2 Americas Imatinib Drugs Sales by Type
5.3 Americas Imatinib Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Imatinib Drugs Sales by Region
6.1.1 APAC Imatinib Drugs Sales by Region (2016-2021)
6.1.2 APAC Imatinib Drugs Revenue by Region (2016-2021)
6.2 APAC Imatinib Drugs Sales by Type
6.3 APAC Imatinib Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Imatinib Drugs by Country
7.1.1 Europe Imatinib Drugs Sales by Country (2016-2021)
7.1.2 Europe Imatinib Drugs Revenue by Country (2016-2021)
7.2 Europe Imatinib Drugs Sales by Type
7.3 Europe Imatinib Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Imatinib Drugs by Country
8.1.1 Middle East & Africa Imatinib Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Imatinib Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Imatinib Drugs Sales by Type
8.3 Middle East & Africa Imatinib Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Imatinib Drugs Distributors
10.3 Imatinib Drugs Customer

11 Global Imatinib Drugs Market Forecast
11.1 Global Imatinib Drugs Forecast by Region
11.1.1 Global Imatinib Drugs Forecast by Regions (2021-2026)
11.2.2 Global Imatinib Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Imatinib Drugs Forecast by Type
11.7 Global Imatinib Drugs Forecast by Application

12 Key Players Analysis
12.1 Apotex Inc.
12.1.1 Apotex Inc. Apotex Inc. Company Information
12.1.2 Apotex Inc. Imatinib Drugs Product Offered
12.1.3 Apotex Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Apotex Inc. Main Business Overview
12.1.5 Apotex Inc. Latest Developments
12.2 Novartis
12.2.1 Novartis Company Information
12.2.2 Novartis Imatinib Drugs Product Offered
12.2.3 Novartis Imatinib Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Novartis Main Business Overview
12.2.5 Novartis Latest Developments
12.3 Sanofi S.A.
12.3.1 Sanofi S.A. Company Information
12.3.2 Sanofi S.A. Imatinib Drugs Product Offered
12.3.3 Sanofi S.A. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Sanofi S.A. Main Business Overview
12.3.5 Sanofi S.A. Latest Developments
12.4 Cipla Inc.
12.4.1 Cipla Inc. Company Information
12.4.2 Cipla Inc. Imatinib Drugs Product Offered
12.4.3 Cipla Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Cipla Inc. Main Business Overview
12.4.5 Cipla Inc. Latest Developments
12.5 Mylan Pharms Inc.
12.5.1 Mylan Pharms Inc. Company Information
12.5.2 Mylan Pharms Inc. Imatinib Drugs Product Offered
12.5.3 Mylan Pharms Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Mylan Pharms Inc. Main Business Overview
12.5.5 Mylan Pharms Inc. Latest Developments
12.6 Glenmark Pharmaceuticals Ltd.
12.6.1 Glenmark Pharmaceuticals Ltd. Company Information
12.6.2 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Product Offered
12.6.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Glenmark Pharmaceuticals Ltd. Main Business Overview
12.6.5 Glenmark Pharmaceuticals Ltd. Latest Developments
12.7 Sun Pharmaceuticals
12.7.1 Sun Pharmaceuticals Company Information
12.7.2 Sun Pharmaceuticals Imatinib Drugs Product Offered
12.7.3 Sun Pharmaceuticals Imatinib Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Sun Pharmaceuticals Main Business Overview
12.7.5 Sun Pharmaceuticals Latest Developments
12.8 Actavis Generics
12.8.1 Actavis Generics Company Information
12.8.2 Actavis Generics Imatinib Drugs Product Offered
12.8.3 Actavis Generics Imatinib Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Actavis Generics Main Business Overview
12.8.5 Actavis Generics Latest Developments
12.9 Dr. Reddy’s Laboratories
12.9.1 Dr. Reddy’s Laboratories Company Information
12.9.2 Dr. Reddy’s Laboratories Imatinib Drugs Product Offered
12.9.3 Dr. Reddy’s Laboratories Imatinib Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Dr. Reddy’s Laboratories Main Business Overview
12.9.5 Dr. Reddy’s Laboratories Latest Developments
12.10 Teva Pharmaceutical Industries Ltd.
12.10.1 Teva Pharmaceutical Industries Ltd. Company Information
12.10.2 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Product Offered
12.10.3 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
12.10.5 Teva Pharmaceutical Industries Ltd. Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Imatinib Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Capsules
Table 3. Major Players of Tablets
Table 4. Global Imatinib Drugs Sales by Type (2016-2021) & (K MT)
Table 5. Global Imatinib Drugs Sales Market Share by Type (2016-2021)
Table 6. Global Imatinib Drugs Revenue by Type (2016-2021) & ($ million)
Table 7. Global Imatinib Drugs Revenue Market Share by Type (2016-2021)
Table 8. Global Imatinib Drugs Sale Price by Type (2016-2021)
Table 9. Global Imatinib Drugs Sales by Application (2016-2021) & (K MT)
Table 10. Global Imatinib Drugs Sales Market Share by Application (2016-2021)
Table 11. Global Imatinib Drugs Value by Application (2016-2021)
Table 12. Global Imatinib Drugs Revenue Market Share by Application (2016-2021)
Table 13. Global Imatinib Drugs Sale Price by Application (2016-2021)
Table 14. Global Imatinib Drugs Sales by Company (2019-2021) & (K MT)
Table 15. Global Imatinib Drugs Sales Market Share by Company (2019-2021)
Table 16. Global Imatinib Drugs Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Imatinib Drugs Revenue Market Share by Company (2019-2021)
Table 18. Global Imatinib Drugs Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Imatinib Drugs Producing Area Distribution and Sales Area
Table 20. Players Imatinib Drugs Products Offered
Table 21. Imatinib Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Imatinib Drugs Sales by Region (2016-2021) (K MT)
Table 25. Global Imatinib Drugs Sales Market Share by Region (2016-2021)
Table 26. Global Imatinib Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Imatinib Drugs Revenue Market Share by Region (2016-2021)
Table 28. Americas Imatinib Drugs Sales by Country (2016-2021) & (K MT)
Table 29. Americas Imatinib Drugs Sales Market Share by Country (2016-2021)
Table 30. Americas Imatinib Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Imatinib Drugs Revenue Market Share by Country (2016-2021)
Table 32. Americas Imatinib Drugs Sales by Type (2016-2021) & (K MT)
Table 33. Americas Imatinib Drugs Sales Market Share by Type (2016-2021)
Table 34. Americas Imatinib Drugs Sales by Application (2016-2021) & (K MT)
Table 35. Americas Imatinib Drugs Sales Market Share by Application (2016-2021)
Table 36. APAC Imatinib Drugs Sales by Region (2016-2021) & (K MT)
Table 37. APAC Imatinib Drugs Sales Market Share by Region (2016-2021)
Table 38. APAC Imatinib Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Imatinib Drugs Revenue Market Share by Region (2016-2021)
Table 40. APAC Imatinib Drugs Sales by Type (2016-2021) & (K MT)
Table 41. APAC Imatinib Drugs Sales Market Share by Type (2016-2021)
Table 42. APAC Imatinib Drugs Sales by Application (2016-2021) & (K MT)
Table 43. APAC Imatinib Drugs Sales Market Share by Application (2016-2021)
Table 44. Europe Imatinib Drugs Sales by Country (2016-2021) & (K MT)
Table 45. Europe Imatinib Drugs Sales Market Share by Country (2016-2021)
Table 46. Europe Imatinib Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Imatinib Drugs Revenue Market Share by Country (2016-2021)
Table 48. Europe Imatinib Drugs Sales by Type (2016-2021) & (K MT)
Table 49. Europe Imatinib Drugs Sales Market Share by Type (2016-2021)
Table 50. Europe Imatinib Drugs Sales by Application (2016-2021) & (K MT)
Table 51. Europe Imatinib Drugs Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Imatinib Drugs Sales by Country (2016-2021) & (K MT)
Table 53. Middle East & Africa Imatinib Drugs Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Imatinib Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Imatinib Drugs Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Imatinib Drugs Sales by Type (2016-2021) & (K MT)
Table 57. Middle East & Africa Imatinib Drugs Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Imatinib Drugs Sales by Application (2016-2021) & (K MT)
Table 59. Middle East & Africa Imatinib Drugs Sales Market Share by Application (2016-2021)
Table 60. Global Imatinib Drugs Sales Forecast by Type (2021-2026) & (K MT)
Table 61. Global Imatinib Drugs Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Imatinib Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Imatinib Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Imatinib Drugs Sales Forecast by Application (2021-2026) & (K MT)
Table 65. Global Imatinib Drugs Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Imatinib Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Imatinib Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 68. Apotex Inc. Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 69. Apotex Inc. Imatinib Drugs Product Offered
Table 70. Apotex Inc. Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 71. Apotex Inc. Main Business
Table 72. Apotex Inc. Latest Developments
Table 73. Novartis Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Novartis Imatinib Drugs Product Offered
Table 75. Novartis Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 76. Novartis Main Business
Table 77. Novartis Latest Developments
Table 78. Sanofi S.A. Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi S.A. Imatinib Drugs Product Offered
Table 80. Sanofi S.A. Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 81. Sanofi S.A. Main Business
Table 82. Sanofi S.A. Latest Developments
Table 83. Cipla Inc. Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Cipla Inc. Imatinib Drugs Product Offered
Table 85. Cipla Inc. Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 86. Cipla Inc. Main Business
Table 87. Cipla Inc. Latest Developments
Table 88. Mylan Pharms Inc. Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Mylan Pharms Inc. Imatinib Drugs Product Offered
Table 90. Mylan Pharms Inc. Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 91. Mylan Pharms Inc. Main Business
Table 92. Mylan Pharms Inc. Latest Developments
Table 93. Glenmark Pharmaceuticals Ltd. Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Product Offered
Table 95. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 96. Glenmark Pharmaceuticals Ltd. Main Business
Table 97. Glenmark Pharmaceuticals Ltd. Latest Developments
Table 98. Sun Pharmaceuticals Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Sun Pharmaceuticals Imatinib Drugs Product Offered
Table 100. Sun Pharmaceuticals Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 101. Sun Pharmaceuticals Main Business
Table 102. Sun Pharmaceuticals Latest Developments
Table 103. Actavis Generics Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Actavis Generics Imatinib Drugs Product Offered
Table 105. Actavis Generics Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 106. Actavis Generics Main Business
Table 107. Actavis Generics Latest Developments
Table 108. Dr. Reddy's Laboratories Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Dr. Reddy's Laboratories Imatinib Drugs Product Offered
Table 110. Dr. Reddy's Laboratories Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 111. Dr. Reddy's Laboratories Main Business
Table 112. Dr. Reddy's Laboratories Latest Developments
Table 113. Teva Pharmaceutical Industries Ltd. Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Product Offered
Table 115. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 116. Teva Pharmaceutical Industries Ltd. Main Business
Table 117. Teva Pharmaceutical Industries Ltd. Latest Developments
List of Figures
Figure 1. Picture of Imatinib Drugs
Figure 2. Imatinib Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Imatinib Drugs Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global Imatinib Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Imatinib Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Capsules
Figure 10. Product Picture of Tablets
Figure 11. Global Imatinib Drugs Sales Market Share by Type in 2020
Figure 12. Global Imatinib Drugs Revenue Market Share by Type (2016-2021)
Figure 13. Imatinib Drugs Consumed in Hospitals
Figure 14. Global Imatinib Drugs Market: Hospitals (2016-2021) & (K MT)
Figure 15. Imatinib Drugs Consumed in Drug Stores
Figure 16. Global Imatinib Drugs Market: Drug Stores (2016-2021) & (K MT)
Figure 17. Imatinib Drugs Consumed in Other
Figure 18. Global Imatinib Drugs Market: Other (2016-2021) & (K MT)
Figure 19. Global Imatinib Drugs Sales Market Share by Application (2016-2021)
Figure 20. Global Imatinib Drugs Revenue Market Share by Application in 2020
Figure 21. Global Imatinib Drugs Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Imatinib Drugs Revenue Market Share by Company in 2020
Figure 23. Global Imatinib Drugs Sales Market Share by Regions (2016-2021)
Figure 24. Global Imatinib Drugs Revenue Market Share by Region in 2020
Figure 25. Americas Imatinib Drugs Sales 2016-2021 (K MT)
Figure 26. Americas Imatinib Drugs Revenue 2016-2021 ($ Millions)
Figure 27. APAC Imatinib Drugs Sales 2016-2021 (K MT)
Figure 28. APAC Imatinib Drugs Revenue 2016-2021 ($ Millions)
Figure 29. Europe Imatinib Drugs Sales 2016-2021 (K MT)
Figure 30. Europe Imatinib Drugs Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Imatinib Drugs Sales 2016-2021 (K MT)
Figure 32. Middle East & Africa Imatinib Drugs Revenue 2016-2021 ($ Millions)
Figure 33. Americas Imatinib Drugs Sales Market Share by Country in 2020
Figure 34. Americas Imatinib Drugs Revenue Market Share by Country in 2020
Figure 35. Americas Imatinib Drugs Sales Market Share by Type in 2020
Figure 36. Americas Imatinib Drugs Sales Market Share by Application in 2020
Figure 37. United States Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Imatinib Drugs Sales Market Share by Region in 2020
Figure 42. APAC Imatinib Drugs Revenue Market Share by Regions in 2020
Figure 43. APAC Imatinib Drugs Sales Market Share by Type in 2020
Figure 44. APAC Imatinib Drugs Sales Market Share by Application in 2020
Figure 45. China Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Imatinib Drugs Sales Market Share by Country in 2020
Figure 52. Europe Imatinib Drugs Revenue Market Share by Country in 2020
Figure 53. Europe Imatinib Drugs Sales Market Share by Type in 2020
Figure 54. Europe Imatinib Drugs Sales Market Share by Application in 2020
Figure 55. Germany Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Imatinib Drugs Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Imatinib Drugs Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Imatinib Drugs Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Imatinib Drugs Sales Market Share by Application in 2020
Figure 64. Egypt Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Imatinib Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles


【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のイマチニブ薬市場2021-2026:カプセル、錠剤(Global Imatinib Drugs Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。